Fibroblast activation protein inhibitor radiotheranostics for imaging activated tumor stroma and guiding radionuclide therapy - Top-Institutions - MDSpire

Fibroblast activation protein inhibitor radiotheranostics for imaging activated tumor stroma and guiding radionuclide therapy

By
Hangyu Wu
Ze Liu
July 10, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

University Hospital Essen

Essen, Germany
Key Differentiators
- Nuclear Medicine
- Oncology
#2

Ruijin Hospital

Shanghai, China
Key Differentiators
- Nuclear Medicine
- Oncology
#3

Winship Cancer Institute of Emory University

Atlanta, Georgia
Key Differentiators
- Oncology
- Radiology
#4

Peking Union Medical College Hospital

Beijing, China
Key Differentiators
- Nuclear Medicine
- Oncology
#5

Heidelberg University Hospital

Heidelberg, Germany
Key Differentiators
- Nuclear Medicine
- Oncology

Original Source(s)

Frontiers In Oncology

Fibroblast activation protein inhibitor radiotheranostics for imaging activated tumor stroma and guiding radionuclide therapy

by Hangyu Wu, Ze Liu
July 10, 2026

Related Content

Frontiers In Immunology

KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis

by Yici Yan, Leyi Zheng, Hongfei Wang, Leitao Sun, Xing Xu
July 10, 2026

Frontiers In Oncology

Therapeutic assessment of Nerium oleander-derived exosome-like nanoparticles against triple-negative breast cancer: a preliminary in vitro and network pharmacology approach

by Sreyoshi Routh, Tomsy Joseph, Arya Sreekumar, Venkatraman Manickam
July 10, 2026

Frontiers In Neurology

Machine and deep learning based on magnetic resonance imaging to segment glioblastoma and predict the spread of recurrence: a multicenter retrospective protocol